Target intelligence / Profile preview

Beta Amyloid Fibril (None)

Target
None
Molecular classification
Protein aggregate, Fibril, Peptide aggregate
01

Overview

Beta amyloid fibrils are insoluble, fibrous protein aggregates formed by the self-assembly of amyloid beta (Aβ) peptides. These fibrils are a hallmark of Alzheimer's disease pathology and are found in the extracellular plaques characteristic of the disorder. The formation and accumulation of beta amyloid fibrils are closely linked to neurodegeneration and cell death in Alzheimer's disease. The fundamental structural motif is the cross-β structure, where β-strands run perpendicular to the long axis of the fibril, forming extended β-sheets that stack parallel to each other along the fiber axis. Fibrils consist of several protofilaments, which laterally associate into mature fibers. In Aβ(1–42) fibrils, residues 18–42 form a β-strand–turn–β-strand motif with two intermolecular, parallel, in-register β-sheets. Residues 1–17 remain disordered. Amyloid beta peptides range from 36–43 amino acids; Aβ(1–40) and Aβ(1–42) are most common in human pathology.

Other names
Amyloid beta fibrilAβ fibrilAmyloid plaque
02

Mechanism of action

Aggregation inhibition (potential)

03

Biological functions

AggregationMisfoldingNeurotoxicity
04

Disease associations

Alzheimer's diseaseNeurodegenerative disease
05

Safety considerations

ImmunogenicityOff-target effectsAmyloid-related imaging abnormalities (ARIA)
06

Biomarkers

Aβ40/Aβ42 ratio in cerebrospinal fluid (CSF)Amyloid PET imaging

Beyond the preview

Go deeper on Beta Amyloid Fibril (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta Amyloid Fibril (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call